The UK medicines regulator has given approval for an experimental vaccine to be tested on healthy adults.

In a Q&A, Kenneth Chien, no longer with Moderna, predicts the company's mRNA cancer vaccine will be transformative for ...

The small Ugandan city of Masaka is known mostly for its coffee, grown on rich volcanic soils that produce beans which have a ...

ATTR-CM treatment options narrowed after AstraZeneca and Ionis revealed their gene-silencing drug Wainua (eplontersen) failed ...

A comprehensive new review published in The Lancet affirms that currently approved mRNA vaccines are safe and highly ...

A review of billions of mRNA vaccine doses finds strong COVID protection across groups, with rare serious side effects ...

Health Minister Budi Gunadi Sadikin sets a target for Indonesia to domestically manufacture all 15 vaccine antigens used in ...

Arcutis doubled revenue last year while Vertex delivered strong profits and cash flow. Explore how each company stacks up on ...

MRK trades above its 50- and 200-day SMAs as pipeline progress, acquisitions and Keytruda strength offset patent and vaccine ...

The FDA's decision on the vaccine ‌is expected by August 5. Jefferies analyst Andrew Tsai does not expect flu revenue for Moderna until ​2027 and sees $750 million of U.S. flu and COVID-flu combo ...

Unexpectedly catapulted into global fame as a COVID-19 vaccine maker, BioNTech is on the verge of returning to its oncology ...